Until now pituitary tumors are considered as benign and usually named ''pituitary
adenomas'', whereas only the very rare pituitary tumors (0.2%) with subarachnoid, brain or …

Context: Although pituitary tumors are common, pituitary carcinoma is very rare and is only
diagnosed when pituitary tumor noncontiguous with the sellar region is demonstrated …

Pituitary carcinomas are rare, making up some 0.2% of all pituitary tumors, but represent a
particular challenge to clinical practice. The diagnosis of a pituitary carcinoma requires …

Aggressive pituitary tumors account for up to 10% of pituitary tumors and are characterized
by resistance to medical treatment and multiple recurrences despite standard therapies …

In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …

Recently there has been significant progress in our understanding of pituitary development,
physiology, and pathology. New information has helped to clarify the classification of …

Context.—The sellar region is the site of frequent pathology. The pituitary is affected by a
large number of pathologic entities arising from the gland itself and from adjacent …

Pituitary adenomas (PA) represent in the majority of cases, benign tumors whose treatment
currently associate surgery, medical therapies and radiotherapy in a multidisciplinary …

Pituitary tumors (PT) represent in, the majority of cases, benign tumors for which surgical
treatment still remains, except for prolactin-secreting PT, the first-line therapeutic option …

The classification of pituitary tumors is a dynamic area that changes with advances in cell
biology that provide a deeper insight and clearer understanding of cell lineages and …